A detailed history of Simplex Trading, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Simplex Trading, LLC holds 6,944 shares of IONS stock, worth $240,887. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,944
Previous 63,347 89.04%
Holding current value
$240,887
Previous $3.02 Million 90.79%
% of portfolio
0.01%
Previous 0.1%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$40.06 - $51.86 $2.26 Million - $2.93 Million
-56,403 Reduced 89.04%
6,944 $278,000
Q2 2024

Jul 25, 2024

BUY
$36.45 - $47.7 $2 Million - $2.61 Million
54,817 Added 642.64%
63,347 $3.02 Million
Q1 2024

Apr 25, 2024

SELL
$42.03 - $53.55 $42,660 - $54,353
-1,015 Reduced 10.63%
8,530 $369,000
Q4 2023

Feb 02, 2024

BUY
$43.39 - $51.63 $414,157 - $492,808
9,545 New
9,545 $482,000
Q1 2023

Apr 27, 2023

SELL
$33.58 - $41.2 $112,526 - $138,061
-3,351 Reduced 76.68%
1,019 $36,000
Q4 2022

Feb 02, 2023

BUY
$37.12 - $46.52 $162,214 - $203,292
4,370 New
4,370 $165,000
Q2 2022

Aug 03, 2022

BUY
$31.71 - $43.0 $968,645 - $1.31 Million
30,547 Added 748.88%
34,626 $1.28 Million
Q1 2022

May 02, 2022

SELL
$29.88 - $37.04 $550,778 - $682,758
-18,433 Reduced 81.88%
4,079 $151,000
Q3 2021

Oct 28, 2021

BUY
$33.54 - $40.55 $38,839 - $46,956
1,158 Added 5.42%
22,512 $901,000
Q2 2021

Aug 12, 2021

BUY
$34.54 - $47.25 $710,798 - $972,357
20,579 Added 2655.35%
21,354 $851,000
Q4 2020

Feb 02, 2021

BUY
$45.3 - $60.27 $35,107 - $46,709
775 New
775 $43,000
Q3 2020

Oct 14, 2020

SELL
$47.45 - $62.95 $507,572 - $673,376
-10,697 Closed
0 $0
Q2 2020

Jul 13, 2020

BUY
$46.85 - $61.05 $219,492 - $286,019
4,685 Added 77.93%
10,697 $630,000
Q1 2020

Apr 29, 2020

BUY
$41.6 - $63.4 $5,907 - $9,002
142 Added 2.42%
6,012 $284,000
Q4 2019

Feb 05, 2020

SELL
$53.85 - $65.27 $558,155 - $676,523
-10,365 Reduced 63.84%
5,870 $354,000
Q3 2019

Oct 15, 2019

SELL
$59.06 - $72.15 $410,348 - $501,298
-6,948 Reduced 29.97%
16,235 $972,000
Q2 2019

Jul 26, 2019

SELL
$62.09 - $86.14 $384,026 - $532,775
-6,185 Reduced 21.06%
23,183 $1.49 Million
Q1 2019

Apr 18, 2019

SELL
$52.92 - $81.17 $219,300 - $336,368
-4,144 Reduced 12.37%
29,368 $0
Q4 2018

Jan 16, 2019

BUY
$43.37 - $59.54 $772,983 - $1.06 Million
17,823 Added 113.6%
33,512 $1.81 Million
Q3 2018

Oct 23, 2018

BUY
$42.88 - $53.7 $457,701 - $573,193
10,674 Added 212.84%
15,689 $809,000
Q2 2018

Jul 30, 2018

SELL
$40.53 - $50.7 $489,278 - $612,050
-12,072 Reduced 70.65%
5,015 $208,000
Q1 2018

Apr 26, 2018

SELL
$44.08 - $55.05 $160,583 - $200,547
-3,643 Reduced 17.57%
17,087 $753,000
Q4 2017

Jan 10, 2018

BUY
$50.3 - $64.39 $1.04 Million - $1.33 Million
20,730
20,730 $1.04 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $4.92B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.